• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Paediatr Child Health . Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus-2 pandemic in Turkey: A

tetano

Editor, Senior Moderator
J Paediatr Child Health


. 2021 Aug 3.
doi: 10.1111/jpc.15674. Online ahead of print.
Multisystem inflammatory syndrome in children during severe acute respiratory syndrome coronavirus-2 pandemic in Turkey: A single-centre experience


Zeynep Savas Sen[SUP] 1 [/SUP], Gonul Tanir[SUP] 1 [/SUP], Ruveyda Gumuser Cinni[SUP] 1 [/SUP], Mutlu Uysal Yazici[SUP] 2 [/SUP], Tamer Yoldas[SUP] 3 [/SUP], Zeynelabidin Ozturk[SUP] 2 [/SUP], Mete Han Kizilkaya[SUP] 3 [/SUP], Suna Ozdem[SUP] 1 [/SUP], Rumeysa Yalcinkaya[SUP] 1 [/SUP], Caner Ozturk[SUP] 4 [/SUP], Aslihan Yuce Sezen[SUP] 4 [/SUP], Semanur Ozdel[SUP] 5 [/SUP], Betul Emine Derinkuyu[SUP] 6 [/SUP], Meltem Polat[SUP] 1 [/SUP], Fatma Nur Oz[SUP] 1 [/SUP]



Affiliations

Abstract

Aim: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection may result in a life-threatening hyperinflammatory condition named multisystem inflammatory syndrome in children (MIS-C). We aimed to assess demographics, clinical presentations, laboratory characteristics and treatment outcomes of patients with MIS-C.
Methods: We performed a retrospective study of patients with MIS-C managed between August 2020 and March 2021 at Dr. Sami Ulus Maternity Child Health and Diseases Training and Research Hospital in Turkey.
Results: A total of 45 patients (23 male, 51%) with a median age of 8.7 years (interquartile range: 5.6-11.7 years) were enrolled to study. The SARS-CoV-2 serology was positive in 43 (95%) patients. Organ-system involvement included the dermatologic in 41 (91%), cardiovascular in 39 (87%), hematologic in 36 (80%) and gastrointestinal in 36 (80%) patients. Acute anterior uveitis was diagnosed in nine (20%) patients. Two patients presented with clinical findings of deep neck infection such as fever, neck pain, trismus, swelling and induration on the cervical lymph node. One patient presented with Henoch-Schonlein purpura-like eruption. Coronary artery dilatation was detected in five (11%) patients. For treatment of MIS-C, intravenous immunoglobulin was used in 44 (98%) patients, methylprednisolone in 27 (60%) and anakinra in 9 (20%) patients. The median duration of hospitalisation was nine days. All patients recovered.
Conclusions: Children with MIS-C might have variable clinical presentations. Acute anterior uveitis might be a prominent presentation of MIS-C and require ophthalmological examination. It is essential to make patient-based decisions and apply a stepwise approach for the treatment of this life-threatening disease.

Keywords: SARS-CoV-2; acute anterior uveitis; children; multisystem inflammatory syndrome associated with COVID-19.
 
Back
Top Bottom